NME2 and gastric cancer: Based on the gene expression profile of NME2 in the cancerous tissues of cancer patients and healthy donors using the Cancer Genome Atlas (TCGA) database, NME2 was significantly upregulated in the cancerous tissues of gastric cancer patients compared with that of the healthy donors (Fig. 1D).